Harmonization of individual case safety reports transmission requirements among PAHO reference authorities: a review of their current regulation

To perform optimal monitoring of the safety profile in the postmarketing phase, Marketing Authorization Holders and National Regulatory Authorities (NRAs) must evaluate the adverse drug reactions (ADRs) that occurred and characterize their nature, frequency, and severity. Management is possible thro...

Full description

Bibliographic Details
Main Authors: Antonio Lomeli-Silva, Homero Contreras-Salinas, Mayra Yolanda Barajas-Virgen, Maria Soledad Romero-Lopez, Lourdes Yolotzin Rodríguez-Herrera
Format: Article
Language:English
Published: SAGE Publishing 2024-02-01
Series:Therapeutic Advances in Drug Safety
Online Access:https://doi.org/10.1177/20420986241228119
_version_ 1797324064247775232
author Antonio Lomeli-Silva
Homero Contreras-Salinas
Mayra Yolanda Barajas-Virgen
Maria Soledad Romero-Lopez
Lourdes Yolotzin Rodríguez-Herrera
author_facet Antonio Lomeli-Silva
Homero Contreras-Salinas
Mayra Yolanda Barajas-Virgen
Maria Soledad Romero-Lopez
Lourdes Yolotzin Rodríguez-Herrera
author_sort Antonio Lomeli-Silva
collection DOAJ
description To perform optimal monitoring of the safety profile in the postmarketing phase, Marketing Authorization Holders and National Regulatory Authorities (NRAs) must evaluate the adverse drug reactions (ADRs) that occurred and characterize their nature, frequency, and severity. Management is possible through Individual Case Safety Reports (ICSRs), which are the reports of organized and processed data. Globally, the International Council for Harmonisation (ICH) E2B guideline suggests harmonized activities for the ICSR electronic content and transmission. In America, the Pan American Health Organization (PAHO) is the agency responsible to implement cooperation among its members, which are recognized as National Regulatory Authorities of Reference (NRARs) such as Argentina, Brazil, Canada, Chile, Colombia, Cuba, Mexico, and the United States. PAHO published the ‘Good Pharmacovigilance Practices for the Americas’ suggesting improvement and harmonization in the region. After reviewing the regulatory framework, it is assumed that all NRARs have a regulated ICSR transmission system (i.e. a systematic vigilance system for collecting, analyzing, and disseminating information from ADRs). However, significant differences exist, such as the requirement for social media vigilance, expedited and non-expedited ICSRs, coding, severity, and transmission. The volume of ICSRs has significantly increased, due to using electronic standards managed by the NRAs, which facilitates early identification of new ADRs, allowing the implementation of novel minimization activities, contributing to the continuous assessment of the benefit-risk balance of medicines. Nevertheless, there is still area for improvement, especially in Latin America.
first_indexed 2024-03-08T05:44:52Z
format Article
id doaj.art-860b0c1ce2494ed0bc97c65758525f1e
institution Directory Open Access Journal
issn 2042-0994
language English
last_indexed 2024-03-08T05:44:52Z
publishDate 2024-02-01
publisher SAGE Publishing
record_format Article
series Therapeutic Advances in Drug Safety
spelling doaj.art-860b0c1ce2494ed0bc97c65758525f1e2024-02-05T14:04:37ZengSAGE PublishingTherapeutic Advances in Drug Safety2042-09942024-02-011510.1177/20420986241228119Harmonization of individual case safety reports transmission requirements among PAHO reference authorities: a review of their current regulationAntonio Lomeli-SilvaHomero Contreras-SalinasMayra Yolanda Barajas-VirgenMaria Soledad Romero-LopezLourdes Yolotzin Rodríguez-HerreraTo perform optimal monitoring of the safety profile in the postmarketing phase, Marketing Authorization Holders and National Regulatory Authorities (NRAs) must evaluate the adverse drug reactions (ADRs) that occurred and characterize their nature, frequency, and severity. Management is possible through Individual Case Safety Reports (ICSRs), which are the reports of organized and processed data. Globally, the International Council for Harmonisation (ICH) E2B guideline suggests harmonized activities for the ICSR electronic content and transmission. In America, the Pan American Health Organization (PAHO) is the agency responsible to implement cooperation among its members, which are recognized as National Regulatory Authorities of Reference (NRARs) such as Argentina, Brazil, Canada, Chile, Colombia, Cuba, Mexico, and the United States. PAHO published the ‘Good Pharmacovigilance Practices for the Americas’ suggesting improvement and harmonization in the region. After reviewing the regulatory framework, it is assumed that all NRARs have a regulated ICSR transmission system (i.e. a systematic vigilance system for collecting, analyzing, and disseminating information from ADRs). However, significant differences exist, such as the requirement for social media vigilance, expedited and non-expedited ICSRs, coding, severity, and transmission. The volume of ICSRs has significantly increased, due to using electronic standards managed by the NRAs, which facilitates early identification of new ADRs, allowing the implementation of novel minimization activities, contributing to the continuous assessment of the benefit-risk balance of medicines. Nevertheless, there is still area for improvement, especially in Latin America.https://doi.org/10.1177/20420986241228119
spellingShingle Antonio Lomeli-Silva
Homero Contreras-Salinas
Mayra Yolanda Barajas-Virgen
Maria Soledad Romero-Lopez
Lourdes Yolotzin Rodríguez-Herrera
Harmonization of individual case safety reports transmission requirements among PAHO reference authorities: a review of their current regulation
Therapeutic Advances in Drug Safety
title Harmonization of individual case safety reports transmission requirements among PAHO reference authorities: a review of their current regulation
title_full Harmonization of individual case safety reports transmission requirements among PAHO reference authorities: a review of their current regulation
title_fullStr Harmonization of individual case safety reports transmission requirements among PAHO reference authorities: a review of their current regulation
title_full_unstemmed Harmonization of individual case safety reports transmission requirements among PAHO reference authorities: a review of their current regulation
title_short Harmonization of individual case safety reports transmission requirements among PAHO reference authorities: a review of their current regulation
title_sort harmonization of individual case safety reports transmission requirements among paho reference authorities a review of their current regulation
url https://doi.org/10.1177/20420986241228119
work_keys_str_mv AT antoniolomelisilva harmonizationofindividualcasesafetyreportstransmissionrequirementsamongpahoreferenceauthoritiesareviewoftheircurrentregulation
AT homerocontrerassalinas harmonizationofindividualcasesafetyreportstransmissionrequirementsamongpahoreferenceauthoritiesareviewoftheircurrentregulation
AT mayrayolandabarajasvirgen harmonizationofindividualcasesafetyreportstransmissionrequirementsamongpahoreferenceauthoritiesareviewoftheircurrentregulation
AT mariasoledadromerolopez harmonizationofindividualcasesafetyreportstransmissionrequirementsamongpahoreferenceauthoritiesareviewoftheircurrentregulation
AT lourdesyolotzinrodriguezherrera harmonizationofindividualcasesafetyreportstransmissionrequirementsamongpahoreferenceauthoritiesareviewoftheircurrentregulation